Values as of: 2025-01-08
COMMON STOCK | Medical Devices |
Last Closing
USD 0.07Change
0.00 (0.00)%Market Cap
USD 0.02BVolume
0.49MAnalyst Target
N/AVerdict
Verdict
MedX Health Corp develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, Europe, and internationally. The company offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; and phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide treatment for pain and tissue damage in the rehabilitation market. It also operates DermSecure telemedicine platform that enables the web-based operation of its SIAscopy scanning technology and allows the company to deploy its technology in networks of third-party locations from which patients' mole and lesion images along with other relevant patient information can be connected to specialist physicians for remote assessment. MedX Health Corp was incorporated in 1999 and is headquartered in Mississauga, Canada.
Company Website : https://www.medxhealth.com
Currency: CAD
Country : Canada
| Symbol | Name | Price(Change) | Market Cap |
|---|---|---|---|
| TLT:CA | Theralase Technologies Inc. |
-0.01 (-1.64%) |
USD 0.07B |
| PINK:CA | Perimeter Medical Imaging AI I.. |
+0.03 (+6.02%) |
USD 0.05B |
| ASG:CA | Aurora Spine Corp |
+0.01 (+2.13%) |
USD 0.03B |
| NGMD:CA | NuGen Medical Devices Inc |
N/A |
USD 0.02B |
| VPT:CA | VentriPoint Diagnostics Ltd |
+0.01 (+4.76%) |
USD 0.02B |
| THRM:CA | Therma Bright Inc |
-0.01 (-12.50%) |
USD 0.01B |
| EVMT:CA | Evome Medical Technologies Inc.. |
+0.01 (+3.45%) |
USD 0.01B |
| FREQ:CA | Frequency Exchange Corp. |
N/A |
USD 0.01B |
| CNVI:CA | Conavi Medical Corp. |
-0.05 (-7.35%) |
N/A |
N/A
| Market Performance vs. Industry/Classification (Medical Devices) | Market Performance vs. Exchange | ||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| YTD | |||||||
| Capital Gain | 16.67% | 89% | A- | 72% | C | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | 16.67% | 89% | A- | 72% | C | ||
| Trailing 12 Months | |||||||
| Capital Gain | 16.67% | 50% | F | 69% | C- | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | 16.67% | 50% | F | 69% | C- | ||
| Trailing 5 Years | |||||||
| Capital Gain | -48.15% | 20% | F | 44% | F | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | -48.15% | 20% | F | 43% | F | ||
| Average Annual (5 Year Horizon) | |||||||
| Capital Gain | -3.83% | 25% | F | 46% | F | ||
| Dividend Return | -3.83% | 25% | F | 46% | F | ||
| Total Return | N/A | N/A | N/A | N/A | N/A | ||
| Risk Return Profile | |||||||
| Volatility (Standard Deviation) | 48.52% | 75% | C | 54% | F | ||
| Risk Adjusted Return | -7.89% | 25% | F | 46% | F | ||
| Market Capitalization | 0.02B | 67% | D+ | 71% | C- | ||
| Target Price Action | Rating Action | Analyst | Rating | Price | Date |
|---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
The company had negative total cash flow in the most recent four quarters.
The company had negative total free cash flow in the most recent four quarters.
This stock has shown below median revenue growth in the previous 5 years compared to its sector
